Ignite Creation Date:
2024-05-06 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06090214
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-19
First Post:
2023-10-05
Brief Title:
Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid BLADE
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Circulating Tumor Cells for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid a Pilot Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BLADE
Brief Summary:
The role of this transversal study is to assess the specificity and sensitivity of liquid biopsy to detect circulating cells tumor of adenocarcinoma of the ethmoid
Blood sample of participants will be collected at the moment of the surgical procedure or recurrence diagnosis immediately after surgery at day 8-10 at month 2-3 of postoperative follow-up
Two comparison groups will be studied one age and gender-matched group and one professional exposure-matched group to assess the sensitivity and specificity of liquid biopsy
Blood sample of participants will be collected at the moment of the surgical procedure or recurrence diagnosis immediately after surgery at day 8-10 at month 2-3 of postoperative follow-up
Two comparison groups will be studied one age and gender-matched group and one professional exposure-matched group to assess the sensitivity and specificity of liquid biopsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None